» Articles » PMID: 31971334

Immobilization of Nanocarriers Within a Porous Chitosan Scaffold for the Sustained Delivery of Growth Factors in Bone Tissue Engineering Applications

Overview
Date 2020 Jan 24
PMID 31971334
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

To guide the natural bone regeneration process, bone tissue engineering strategies rely on the development of a scaffold architecture that mimics the extracellular matrix and incorporates important extracellular signaling molecules, which promote fracture healing and bone formation pathways. Incorporation of growth factors into particles embedded within the scaffold can offer both protection of protein bioactivity and a sustained release profile. In this work, a novel method to immobilize carrier nanoparticles within scaffold pores is proposed. A biodegradable, osteoconductive, porous chitosan scaffold was fabricated via the "freeze-drying method," leading to scaffolds with a storage modulus of 8.5 kPa and 300 μm pores, in line with existing bone scaffold properties. Next, poly(methyl methacrylate-co-methacrylic acid) nanoparticles were synthesized and immobilized to the scaffold via carbodiimide-crosslinker chemistry. A fluorescent imaging study confirmed that the conventional methods of protein and nanocarrier incorporation into scaffolds can lead to over 60% diffusion out of the scaffold within the first 5 min of implantation, and total disappearance within 4 weeks. The novel method of nanocarrier immobilization to the scaffold backbone via carbodiimide-crosslinker chemistry allows full retention of particles for up to 4 weeks within the scaffold bulk, with no negative effects on the viability and proliferation of human umbilical vein endothelial cells.

Citing Articles

Biofabrication of functional bone tissue: defining tissue-engineered scaffolds from nature.

Rifai A, Weerasinghe D, Tilaye G, Nisbet D, Hodge J, Pasco J Front Bioeng Biotechnol. 2023; 11:1185841.

PMID: 37614632 PMC: 10444209. DOI: 10.3389/fbioe.2023.1185841.


Hydrogel-guided strategies to stimulate an effective immune response for vaccine-based cancer immunotherapy.

Lei L, Huang D, Gao H, He B, Cao J, Peppas N Sci Adv. 2022; 8(47):eadc8738.

PMID: 36427310 PMC: 9699680. DOI: 10.1126/sciadv.adc8738.


Silicon dioxide nanoparticles decorated on graphene oxide nanosheets and their application in poly(l-lactic acid) scaffold.

Shuai C, Yang F, Shuai Y, Peng S, Chen S, Deng Y J Adv Res. 2022; 48:175-190.

PMID: 36087925 PMC: 10248880. DOI: 10.1016/j.jare.2022.08.017.


Growth Factor Immobilization Strategies for Musculoskeletal Disorders.

Pearson J, Temenoff J Curr Osteoporos Rep. 2022; 20(1):13-25.

PMID: 35118607 PMC: 10772941. DOI: 10.1007/s11914-022-00718-x.


Research Progress of Chitosan-Based Biomimetic Materials.

Zhang Z, Zhang L, Li C, Xie X, Li G, Hu Z Mar Drugs. 2021; 19(7).

PMID: 34199126 PMC: 8307383. DOI: 10.3390/md19070372.


References
1.
Oryan A, Alidadi S, Moshiri A, Maffulli N . Bone regenerative medicine: classic options, novel strategies, and future directions. J Orthop Surg Res. 2014; 9(1):18. PMC: 3995444. DOI: 10.1186/1749-799X-9-18. View

2.
Jin R, Teixeira L, Dijkstra P, Karperien M, van Blitterswijk C, Zhong Z . Injectable chitosan-based hydrogels for cartilage tissue engineering. Biomaterials. 2009; 30(13):2544-51. DOI: 10.1016/j.biomaterials.2009.01.020. View

3.
Chen D, Zhao M, Mundy G . Bone morphogenetic proteins. Growth Factors. 2004; 22(4):233-41. DOI: 10.1080/08977190412331279890. View

4.
Simmons C, Alsberg E, Hsiong S, Kim W, Mooney D . Dual growth factor delivery and controlled scaffold degradation enhance in vivo bone formation by transplanted bone marrow stromal cells. Bone. 2004; 35(2):562-9. DOI: 10.1016/j.bone.2004.02.027. View

5.
Amini A, Laurencin C, Nukavarapu S . Bone tissue engineering: recent advances and challenges. Crit Rev Biomed Eng. 2013; 40(5):363-408. PMC: 3766369. DOI: 10.1615/critrevbiomedeng.v40.i5.10. View